NASDAQ:MYOK
Delisted

Myokardia Stock News

etoro logo Buy MYOK
*Your capital is at risk
$224.91
+0 (+0%)
At Close: May 27, 2022
Myokardia Inc (NASDAQ:MYOK) CEO Anastasios Gianakakos sold 1,000 shares of Myokardia stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $55.00, for a total
Myokardia (NASDAQ:MYOK) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday, BidAskClub reports. Sev
Myokardia Inc (NASDAQ:MYOK) shares traded up 5.7% during trading on Thursday after Morgan Stanley raised their price target on the stock from $76.00 to $83.00. Morgan Stanley currently has an overweig
Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on MyoKardia (MYOK) today and set a price target of $83.00. The company's shares closed last
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
Myokardia Inc (NASDAQ:MYOK) CEO Anastasios Gianakakos sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, April 8th. The shares were sold at an average price of $50.00
Myokardia Inc (NASDAQ:MYOK) CFO Taylor C. Harris sold 1,305 shares of the firm’s stock in a transaction that occurred on Monday, April 6th. The stock was sold at an average price of $46.99, for a to
Cubist Systematic Strategies LLC increased its stake in shares of Myokardia Inc (NASDAQ:MYOK) by 7.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange
Bank of New York Mellon Corp increased its holdings in shares of Myokardia Inc (NASDAQ:MYOK) by 11.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securi
Q1 2019 MyoKardia Inc Earnings Call
Investors need to pay close attention to MyoKardia (MYOK) stock based on the movements in the options market lately.
Investors need to pay close attention to MyoKardia (MYOK) stock based on the movements in the options market lately.
Myokardia Inc (NASDAQ:MYOK) CEO Anastasios Gianakakos sold 2,500 shares of the firm’s stock in a transaction dated Thursday, April 2nd. The stock was sold at an average price of $44.77, for a total
Equities research analysts predict that Myokardia Inc (NASDAQ:MYOK) will report earnings of ($1.38) per share for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates fo
Raymond James & Associates increased its stake in shares of Myokardia Inc (NASDAQ:MYOK) by 20.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE